Olaparib | C24H23FN4O3 | CID 23725625 - PubChem
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Supplementary appendix
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
olaparib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Olaparib - Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
HemOnc.org | A Hematology Oncology Wiki
Olaparib - Wikipedia, la enciclopedia libre
PARP inhibitors: Synthetic lethality in the clinic | Science
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
763113-22-0 Olaparib - Watson International Ltd
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
BRCA Support Liverpool
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment - ScienceDirect
HemOnc.org | A Hematology Oncology Wiki
PharmaWiki - Olaparib
令癌莎- Wikiwand
![Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805122020856-ga1.jpg "Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect")
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect
Olaparib - Wikipedia
Olaparib | C24H23FN4O3 | ChemSpider
Olaparib | AZD-2281 | CAS#763113-22-0 | MedKoo
Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
